ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALNY Alnylam Pharmaceuticals Inc

154.33
0.00 (0.00%)
Pre Market
Last Updated: 20:30:01
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 258.54M213.26M224.82M264.31M335.04M319.29M318.75M750.53M
Operating Income -194.56M-146.73M-191.69M-258.04M-188.61M-149.81M-229.83M213.87M
Pre Tax Income -260.3M-239.36M-274.67M-405.94M-207.02M-172.36M-274.21M150.74M
Net Income -258.46M-240.34M-277.4M-405.92M-207.49M-174.1M-276.02M147.75M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -213.87M-198.01M-231.05M-288.27M-73.95M-153.32M-273.99M156.21M
EBITDA -183.19M-137.27M-181.59M-247.44M-174.3M-135.74M-216.65M227.2M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 47.16M89.91M74.91M219.75M492.85M844.29M1.04B1.83B
Operating Income -424.59M-500.09M-814.67M-939.43M-828.44M-708.65M-785.07M-282.18M
Pre Tax Income -410.11M-490.87M-760.67M-885.25M-855.6M-852.14M-1.13B-433.52M
Net Income -410.11M-490.87M-761.5M-886.12M-858.28M-852.82M-1.13B-440.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.772-4.925-7.526-7.898-7.372-7.096-9.128-3.508
EBIT -418.42M-503.11M-789.94M-918.7M-782.91M-727.96M-791.28M-407.86M
EBITDA -414.99M-488.19M-801.87M-922.83M-798.24M-661.09M-740.6M-228.12M

Your Recent History

Delayed Upgrade Clock